Use of Spreader Flaps Without Dorsal Hump Reduction and the Effect on Nasal Function

Abstract

Importance

Internal nasal valve (INV) collapse is a common cause of nasal obstruction, and spreader grafts are the established standard of treatment. Recently, spreader flaps have gained attention in the treatment of nasal valve stenosis when performed in conjunction with dorsal hump reduction. To date, the efficacy of the spreader flap technique without dorsal hump reduction has not been previously described.

Objective

To determine whether spreader flaps are equivalent to spreader grafts in correcting INV collapse in the absence of simultaneous dorsal hump reduction.

Design, Setting, and Participants

This retrospective medical record review included 26 patients with nasal obstruction and INV collapse who underwent correction with spreader flaps or spreader grafts concurrently with septoplasty and inferior turbinate reduction but without dorsal hump reduction. The type of graft placed was based on surgeon preference and patient anatomy. Patients were treated at a tertiary academic medical center from September 1, 2012, through August 31, 2014, and had follow‐up of at least 6 months. Follow‐up was completed for this study on August 12, 2016.

Main Outcomes and Measures

All patients completed the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire preoperatively and at 1, 3, and 6 months postoperatively. The latest postoperative NOSE score was compared with the preoperative score.

Results

Among the 26 patients included (12 men and 14 women; mean age, 38.4 years [range, 18–64 years]), 13 underwent spreader flap placement and 13 underwent spreader graft placement. No difference was found between patient demographic characteristics or mean (SD) preoperative NOSE score (spreader flap group, 81.9 [15.8]; range, 72.4–91.4; spreader graft group, 75.4 [19.3]; range, 63.7–87.1) between groups. In addition, no difference was found in mean (SD) postoperative NOSE score (spreader flap group, 18.5 [21.6]; range, 5.4–31.5; spreader graft group, 16.9 [16.4]; range, 7.0–26.8), total NOSE score improvement (spreader flap group, 63.5 [23.5]; range, 49.3–77.7; spreader graft group, 58.5 [27.8]; range, 41.7–75.3), or percentage of improvement in NOSE score (spreader flap group, 78.0% [23.8%]; range, 63.6%–92.4%; spreader graft group, 76.02% [26.31%]; range, 60.1%–91.9%) between groups.

Conclusions and Relevance

In appropriately selected patients, spreader flaps are equivalent to spreader grafts in correcting nasal obstruction secondary to INV collapse.

Level of Evidence

Get full access to this article

View all access options for this article.

References

Rhee JS, Weaver EM, Park SS, et al. Clinical consensus statement: diagnosis and management of nasal valve compromise. Otolaryngol Head Neck Surg. 2010;143(1):48–59.

Goode RL. Surgery of the incompetent nasal valve. Laryngoscope. 1985;95(5):546–555.

Sheen JH. Spreader graft: a method of reconstructing the roof of the middle nasal vault following rhinoplasty. Plast Reconstr Surg. 1984;73(2):230–239.

Moubayed SP, Most SP. The autospreader flap for midvault reconstruction following dorsal hump resection. Facial Plast Surg. 2016;32(1):36–41.

Saedi B, Amali A, Gharavis V, Yekta BG, Most SP. Spreader flaps do not change early functional outcomes in reduction rhinoplasty: a randomized control trial [published corrections appear in Am J Rhinol Allergy. 2014;28(6):513 and Am J Rhinol Allergy. 2015;29(6):456]. Am J Rhinol Allergy. 2014;28(1):70–74.

Oneal RM, Berkowitz RL. Upper lateral cartilage spreader flaps in rhinoplasty. Aesthet Surg J. 1998;18(5):370–371.

Wurm J, Kovacevic M. A new classification of spreader flap techniques. Facial Plast Surg. 2013;29(6):506–514.

Neu BR. Use of the upper lateral cartilage sagittal rotation flap in nasal dorsum reduction and augmentation. Plast Reconstr Surg. 2009;123(3):1079–1087.

Gruber RP, Park E, Newman J, Berkowitz L, Oneal R. The spreader flap in primary rhinoplasty. Plast Reconstr Surg. 2007;119(6):1903–1910.

10.

Byrd HS, Meade RA, Gonyon DL Jr. Using the autospreader flap in primary rhinoplasty. Plast Reconstr Surg. 2007;119(6):1897–1902.

11.

Stewart MG, Witsell DL, Smith TL, Weaver EM, Yueh B, Hannley MT. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol Head Neck Surg. 2004;130(2):157–163.

12.

Yoo S, Most SP. Nasal airway preservation using the autospreader technique: analysis of outcomes using a disease‐specific quality‐of‐life instrument. Arch Facial Plast Surg. 2011;13(4):231–233.

13.

Chambers KJ, Horstkotte KA, Shanley K, Lindsay RW. Evaluation of improvement in nasal obstruction following nasal valve correction in patients with a history of failed septoplasty. JAMA Facial Plast Surg. 2015;17(5):347–350.

14.

Stewart MG, Smith TL, Weaver EM, et al. Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study. Otolaryngol Head Neck Surg. 2004;130(3):283–290.

15.

Park SS. The flaring suture to augment the repair of the dysfunctional nasal valve. Plast Reconstr Surg. 1998;101(4):1120–1122.

16.

Grigoryants V, Baroni A. The use of short spreader grafts in rhinoplasty for patients with thick nasal skin. Aesthetic Plast Surg. 2013;37(3):516–520.

17.

Yeung A, Hassouneh B, Kim DW. Outcome of nasal valve obstruction after functional and aesthetic‐functional rhinoplasty. JAMA Facial Plast Surg. 2016;18(2):128–134.

18.

Rhee JS, Kimbell JS. The nasal valve dilemma: the narrow straw vs the weak wall. Arch Facial Plast Surg. 2012;14(1):9–10.